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Aims: To determine if endothelin-1 (ET-1) stimulates the phosphorylation of ERK1/2 in the mouse inner
medullary collecting duct (IMCD), and if this in turn upregulates nitric oxide (NO) production.
Main methods: Conﬂuent mouse IMCD segment-3 cells (mIMCD-3) were stimulated with 50 nM ET-1 for
24 h with and without various doses of ET receptor antagonists, BQ123 (ETA antagonist,) or BQ788 (ETB
antagonist) and phosphorylation of ERK1/2 determined by immunoblots. As well, NOS isoform expression
and nitrite production were assessed. Finally, increasing doses of the MEK inhibitors, PD98,059 or U0126,
were incubated with mIMCD-3 cells and the ET-1 dependent nitrite production determined.
Key ﬁndings: ET-1 via the ETB receptor signiﬁcantly increased ERK1/2 phosphorylation, and was prevented
by MEK inhibition. ET-1 also stimulates nitrite production by mIMCD-3 cells (basal: 54.5±26 pmol/mg pr/h
vs ET-1: 221±28 pmol/mg pr/h; N=4) via the ETB receptor (BQ788+ET-1: 83.7±27 pmol/mg pr/h);
however, ET-1 does not regulate NOS1 or NOS3 expression. MEK inhibition did not prevent the ET-1 stimulated
nitrite production contrary to our initial hypothesis (vehicle+ET-1: 157±13 pmol/mg pr/hr vs PD98,059+ET-
1: 305.7±24 pmol/mg pr/h, N=4, P>0.05).
Signiﬁcance: Although the mouse IMCD-3 cells only express the NOS1β splice variant, ET-1 did regulate mouse
IMCD nitrite production. ET-1 stimulates ERK1/2 phosphorylation in the mouse IMCD, but ERK1/2 signaling is
not involved in the ET-1 dependent increase in NO production by IMCD cells. Thus, we propose that ET-1 regu-
lates protein–protein interactions that are necessary for NO production, that are independent of MAPK signaling
cascades.Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
The endothelin (ET-1) and nitric oxide (NO) systems are highly
expressed in the renal inner medullary collecting ducts (IMCD)
(Kitamura et al., 1989; Ujiie et al., 1992; Wu et al., 1999), and phar-
macological or genetic blockade of either of these systems results in
an elevation in blood pressure (Mattson and Bellehumeur, 1996;
Ahn et al., 2004; Ge et al., 2006; Ge et al., 2008). It is well established
that ET-1 via the ETB receptor can increase NO production in endo-
thelial cells, and the thick ascending limb via NO synthase 3 (NOS3;
eNOS) isoform (Herrera and Garvin, 2004). In the rat IMCD, ET-1 via
the ETB receptor increases NO synthase 1 (NOS1; nNOS) derived NO
production (Stricklett et al., 2006). Interestingly, rat IMCDs express
the NOS1 splice variants, NOS1α and NOS1β (Hyndman et al., 2011;
Smith et al., 2009), while mouse IMCDs express NOS1β (Hyndmantal Medicine, Department of
ciences University, 1459 Laney
1 706 721 8514; fax: +1 706
lock).
 CC BY-NC-ND license.et al., 2011). Puriﬁed NOS1β is reported to have 80% of the activity of
NOS1α (Brenman et al., 1997), yet little is known about the regulation
of NOS1β. By studying mouse IMCDs, it gives the unique opportunity
to determine whether ET-1 regulates NOS1β expression and/or NO
production.
ET-1 has mitogenic properties and activates the mitogen activated
protein kinase (MAPK) pathways. For example, in opossum kidney
cells, proximal tubule epithelial cell line, ET-1 via ETB activates extra-
cellular regulated kinases 1/2 (ERK1/2) indicating a role for the prolif-
erative effects of growth factors on this epithelium (Chu et al., 2007).
Beyond mitogenic activities, activation of ERK1/2 has been linked
to constriction of vascular smooth muscle cells (Watts, 2000);
mineralocorticoid-dependent hypertension (through augmented
vascular smooth muscle contraction) (Giachini et al., 2011); and
endotoxemia (lipopolysaccharide-mediated) linked hypotension
and vascular hyporeactivity (Korkmaz et al., 2011). Several studies
highlight the interaction between ET-1, ERK1/2 activation, and NO
production. There is evidence that ERK1/2 signaling regulates NOS1
expression in rat aortic smoothmuscle (Nakata et al., 2005) aswell as in
neurons and the spinal cord (Cao et al., 2006), NOS2 in the thoracic
aorta (Korkmaz et al., 2011) and astrocytes (Wang et al., 2011).
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Fig. 1. ET-1 regulation of mIMCD-3 nitrite production. A, Predicted scheme of inner
medullary colleting duct ET-1, acting via the ETB receptor to regulate NO production
through a MAPK dependent pathway. B) ETA receptor antagonism with BQ123 does
not prevent the ET-1 (50 nM for 24 h) dependent increase in mIMCD-3 nitrite produc-
tion (Two-Factor ANOVA: antagonist p=0.0025, ET-1 treatment Pb0.0001, interaction
p=0.125). C) ETB receptor antagonism with BQ788 blunts the ET-1 (50 nM for 24 h)
dependent increase in mIMCD-3 nitrite production (Two-Factor ANOVA: drug
p=0.007, ET-1 treatment pb0.001, interaction p=0.002). N=4. *Pb0.05 vehicle vs. ET1.
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onstrating that ERK1/2 regulates NOS3 (Cale and Bird, 2006) while
others suggest these signaling cascades are not involved (Schmidt et
al., 2002).
We hypothesized that ET-1 via the ETB receptor increases ERK1/2
phosphorylation resulting in an increased NO production and/or ex-
pression of NOS1β and/or NOS3 in the IMCD. The objectives of this
study were to determine in mouse IMCD that, (1) ET-1 regulation of
NOS1β and/or NOS3 expression via ETB signaling; (2) ET-1 regulation
of ERK1/2 phosphorylation via ETB signaling; and (3) whether phos-
phorylation of ERK1/2 regulates NO production.
Material and methods
All chemicals were cell culture grade and purchased from Sigma-
Aldrich (St. Louis, MO) unless otherwise stated. Mouse inner medullary
collecting duct segment-3 cells (mIMCD-3) were purchased from ATCC
(Manassas, VA). Passages 3–5were grown in 12-well plates and used in
all studies. Cells were grown in Dulbecco's Modiﬁed Eagle Medium
(DMEM; Invitrogen, Carlsbad, CA) plus 1% penicillin-streptomycin
(Invitrogen) and 10% fetal bovine serum (Atlanta Biologicals,
Lawrenceville, GA) to conﬂuency, and serum/antibiotic starved 3 h
prior to experimentation.
Experiment 1: ET-1 stimulation of nitrite production
mIMCD-3 cells were washed twice with 10 mM Hank's Buffered
Saline Solution (HBSS, with calcium, magnesium, no phenol red (Cell-
gro, Mediatech, Manassas, VA) and incubated for 1 h (37 °C, 5% CO2)
in HBSS+250 μM L-arginine+20 U/ml superoxide dismutase with
one of the following treatments: 0 (water), 1, 10, 50, 100, or
500 nM ET-1 (dissolved in water, American Peptide, Sunnyvale, CA).
Additionally, mMCD-3 cells were pre-incubated with the ETA antago-
nist, BQ123, (dissolved in DMSO) or the ETB antagonist, BQ788, (dis-
solved in DMSO) at 0 (DMSO only), 1, 10, 100, or 1000 nM for 3 h in
DMEM, followed by the addition of 50 nM ET-1 for 24 h. Next, the
cells were washed twice with 10 mM HBSS and incubated in
HBSS+250 μM L-arginine+20 U/ml superoxide dismutase for 1 h.
The HBSS supernatant was removed, snap frozen and stored until ni-
trite analysis (see below). The adherent cells were scraped, pelleted
and snap frozen for Western blot analysis of NOS isoforms (see
below) or dissolved with 0.1 N sodium hydroxide for 20 min at
25 °C. Protein concentrations were determined by Bradford assay fol-
lowing manufacturer's instructions (Biorad Quickstart, Hercules, CA).
Experiment 2: ET-1 activation of ERK1/2
mIMCD-3 cells were washed and incubated in HBSS as stated
above, with the addition of 50 nM ET-1 for 0, 5, 15, 30 and 60 min.
Cells were immediately washed with 10 mM PBS with PhosSTOP™
phosphatase inhibitor (Roche Life Sciences, Indianapolis, IN), scraped,
pelleted and snap frozen for Western blot analysis of ERK1/2 phos-
phorylation status. mIMCD-3 cells were preincubated for 3 h with
0 (DMSO), 1, 10 , 100, or 1000 nM of BQ123 or BQ788 and treated
with 50 nM ET-1 for 15 min. Cells were washed, scraped, pelleted
and frozen for Western blot analysis of ERK1/2 phosphorylation
status.
Experiment 3: MEK inhibition of ET-1 activation of ERK 1/2 and/or nitrite
production
mIMCD-3 cells were preincubated with either, PD98,059 or U0126
(0, 1, 10 100 μM; dissolved in DMSO) for 1 h. Following this, cells
were incubated with 50 nM ET-1 for 15 min, 1 h or 24 h in HBSS+
250 μM L-arginine+20 U/ml superoxide dismutase. The HBSS super-
natants were removed and snap frozen for nitrite analysis. In addition,cells from the 15 min incubationwere scraped, pelleted and snap frozen
for Western blot analysis. Cells were dissolved in 0.1 N NaOH for
20 min, and protein concentration determined.
Western blot analyses
Western blots (5–10 μg of protein loaded/lane) were performed as
previously described (Hyndman et al., 2011). Rabbit monoclonal,
anti-phosphorylated ERK1/2 (Thr202/Tyr204; 1:1000, Cell Signaling
Technology, Danvers, MA), mouse monoclonal, anti-ERK 1/2
(1:1000, Cell Signaling Technology) antibodies were used to analyze
ERK1/2 phosphorylation activation status. NOS isoform speciﬁc expres-
sion was normalized to β-actin expression and analyzed as previously
described (10).
Nitrite measurements
Nitrite production was measured as an index of NO by high-
performance liquid chromatography (ENO20, Eicom, Japan). All
values were recorded as pmol of nitrite/ mg protein/h.
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Fig. 2. ET-1 does not regulate NOS expression in the mIMCD-3. A, B) 50 nM ET-1 given for 24 h did not affect NOS1β expression in the mIMCD-3. Pretreatment for 3 h with various
doses of the ETA antagonist (A), BQ123, or the ETB antagonist (B), BQ788 also did not affect NOS1β expression. C,D) 24 h, 50 nM ET-1 did not affect NOS3 expression in the mIMCD-3.
Likewise, ETA blockade (C) or ETB (D) blockade did not signiﬁcant affect NOS3 expression. N=4.
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All experiments were replicated on different plates of cells 4 times
(N=4). ANOVA and Two-Factor ANOVA (Drug and ET-1 treatment)
were performed where appropriate. Dunnett's post hoc tests were
performed when ANOVA found signiﬁcant differences, and Bonferroni
post hoc test was performed when a Two-Factor ANOVA determined
signiﬁcance. Pb0.05 was considered signiﬁcant.Results
ET-1 regulation of nitrite production in mIMCD-3 cells is ETB receptor
dependent.
We found a signiﬁcant increase in nitrite production with 50 nM and
100 nM ET-1 (221.1±28.4 pmol/mg pr/h and 222.5±33.7 pmol/mg pr/h,
respectively), while 1 nM and 10 nM did not signiﬁcantly increase
nitrite production (51.1±21.3 and 71.4±30.3 pmol/mg pr/h, respec-
tively) over basal nitrite production (54.5±26.3 pmol/mg pr/h). All
remaining experiments utilized 50 nM ET-1. Fig. 1A shows the hypo-
thetical scheme to be tested in this study.
Increasing concentrations of the ETA antagonist, BQ123, or the ETB
antagonist, BQ788, were incubated with cells for 3 h prior to a 24 h
ET-1 treatment. As seen in Fig. 1B, BQ123 did not blunt the ET-1 de-
pendent increase in nitrite production (N=4). However, BQ788 at
10–1000 nM signiﬁcantly attenuated the ET-1 dependent increase in
mIMCD-3 nitrite production (Fig. 1C) (N=4).ET-1 does not regulate NOS1 or NOS3 expression in mIMCD-3 cells
To determine if the increases in nitrite production induced by 24 h
ET-1 treatment in mIMCD-3 cells were dependent on changes in
NOS1 and/or NOS3 expression, Western blots were performed. We
found that mIMCD-3 cells express the NOS1β splice variant similar
to freshly isolated mouse IMCD tubules, while freshly isolated rat
IMCD tubules express both NOS1α and NOS1β (data not shown). Pre-
treatment of BQ123 (Fig. 2A) or BQ788 (Fig. 2B) prior to 24 h incuba-
tion with ET-1 did not alter the NOS1β expression in mIMCD-3 cells.
Likewise, BQ123 (Fig. 2C) or BQ788 (Fig. 2D) did not alter mIMCD-3
NOS3 expression.ET-1 dependent phosphorylation of ERK1/2
mIMCD-3 cells have a low level of basal phosphorylation of ERK1/
2 (Fig. 3A) and p38 MAPK (data not shown). ET-1 (50 nM) caused an
increase in ERK1/2 phosphorylation after 15 and 30 min returning to
basal levels after 60 min. ET-1 treatment did not affect p38 MAPK
phosphorylation (data not shown). mIMCD-3 cells were pretreated
with various concentrations of BQ123 or BQ788 and incubated with
ET-1 for 15 min. As shown in Fig. 3B, BQ123 treatment did not pre-
vent the ET-1 induced phosphorylation of ERK1/2. As well, there
was a concentration-dependent increase in phosphorylated ERK1/2
with increasing concentrations of BQ123 (N=4, ANOVA p=0.0008)
suggesting ETB-mediated activation of ERK1/2. Consequently,
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Fig. 3.mIMCD-3 cell phosphorylation of ERK1/2 by ET-1. A) ET-1 (50 nM) was given for various times to mIMCD-3 and phosphorylation of ERK1/2 measured by Western blot. Peak
phosphorylation occurred after 15 min of ET-1 exposure. B) ETA receptor antagonism (BQ123) leads to an increase in 15 min ET-1 stimulated ERK1/2 phosphorylation. C) ETB re-
ceptor antagonism (BQ788) leads to a decrease in 15 min ET-1 dependent ERK1/2 phosphorylation. D) The MEK1 inhibitor, PD98,059, prevented the phosphorylation of ERK1/2;
however, PD98,059 did not prevent the ET-1 dependent increase in mIMCD-3 nitrite production (E) (Two-Factor ANOVA: Drug p=0.46, ET-1 treatment pb0.0002, interaction
p=0.91). Note nitrite production was calculated as pmol nitrite/mg protein/h. *Pb0.05 compared to time 0 or vehicle. N=4.
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phorylation of ERK1/2 (N=4, ANOVA pb0.0001).
MEK inhibition blocks ERK1/2 phosphorylation but does not affect nitrite
production
MEK, the upstream kinase that phosphorylates ERK1/2 (Brott et
al., 1993; Crews et al., 1992), inhibitors were utilized to validate the
ET-1 dependent activation of ERK1/2 phosphorylation in mIMCD-3
cells. The MEK inhibitors, PD98,059 or U0126, were preincubated
with mIMCD-3 cells for 1 h before ET-1 stimulation. PD98,059 treat-
ment prevented the ET-1 induced phosphorylation of ERK1/2
(Fig. 3D). Similar results were observed with U0126 (data not shown).
PD98,059 (Fig. 3E) and U0126 (data not shown) did not prevent the
ET-1 stimulation of nitrite production (N=4).
Discussion
Here we demonstrate that ET-1 stimulates NO production by the
mouse IMCD via the ETB receptor in agreement with ﬁndings in the
rat IMCD (Stricklett et al., 2006). We hypothesized that ET-1 regulates
IMCD NO production via the MEK/ERK1/2 pathway. ET-1 activates the
MEK/ERK1/2 pathway in the rat nephron (Terada et al., 1995) and our
data conﬁrms that ET-1 activates the MEK/ERK1/2 pathway in the
mouse IMCD via ETB receptor activation. Although ET-1 stimulates
ERK1/2, inhibition of MEK did not prevent the ET-1 dependent in-
crease in nitrite production in mIMCD-3 cells. This was unexpected
because in various cell types ERK1/2 signaling was determined toregulate NO production (Wang et al., 2011) as well as NOS expression
(Giachini et al., 2011; Korkmaz et al., 2011; Nakata et al., 2005; Cao et
al., 2006). Thus, although ET-1 via ETB receptor increases phosphory-
lation of ERK1/2, and increases NO production, these pathways
appear to be independent.
ET-1 regulation of NOS expression is complex, with the nephron
segment (or cell type) and speciﬁc NOS isoforms and/or splice variants
all being contributing factors. We did not ﬁnd an increase in expression
of NOS1 or NOS3 (the NOS isoforms expressed in the IMCD) with ET-1
activation of NO production. In the thick ascending limb (TAL), ET-1
stimulation (for 24 h) via the ETB receptor signiﬁcantly increased
NOS3 expression (the major NOS isoform expressed in the TAL).
Contrary to our ﬁndings presented here, we previously reported
that mIMCD-3 express NOS1α and NOS3 and that exogenous ET-1
via the ETA receptor upregulates NOS1α, while NOS3 was unaffected
(Sullivan et al., 2007). Interestingly, in those experiments, NOS1α
(155 kD) and not NOS1β was expressed in the mIMCD-3 cells. With
our current lot of mIMCD-3 from ATCC (purchased in 2010), we
found only NOS1β (130 kD) expression. Freshly isolated mouse
IMCD expresses NOS1β, exclusively, while the rat IMCD expresses
NOS1α and NOS1β (Hyndman et al., 2011; Smith et al., 2009), thus
the current mIMCD-3 cells appear to be reﬂective of primary mouse
IMCD. Supporting the current ﬁnding that ET-1 does not regulate
NOS1β or NOS3 expression in the IMCD, we previously reported
that collecting-duct speciﬁc ET-1 knockout mice have similar levels
of NOS1β and NOS3 in homogenates of the inner medulla compared
to ﬂox control mice (Schneider et al., 2008). Yet, we also reported
that transgenic ETB deﬁcient rats (sl/sl), with chronic increased
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lary NOS1α and NOS1β expression when compared to wild-type rats
(Sullivan et al., 2007). Thus, further studies are needed to elucidate
whether these differences are species-speciﬁc or model-speciﬁc but
why the mIMCD-3 cells have different NOS1 splice variant expression,
we can only speculate. It is plausible that between the ten years these
two experiments were completed, that due to issues of subculturing
and passaging of cell lines (e.g. Esquenet et al., 1997; Sambuy et al.,
2005; Neumann et al., 2011), the mIMCD-3 have changed. mIMCD-3
were isolated in 1991 (Rauchman et al., 1993), and the previous work
was completed in 2000 and passages 6–9 were used (Sullivan et al.,
2007). In this study, cells were purchased in 2010, and only passages
3–5 were used. Thus, we speculate that protein expression proﬁles
between these two cell cultures, separated by a decade, have changed.
Thus the question remains, how does ET-1 via the ETB receptor
regulate NO production? ET-1 could potentially regulate NO production
through numerous post-translational modiﬁcations of NOS1 and/or
NOS3, which is independent of the MAPK pathways. Phosphorylation
of NOS3 is well documented (e.g. Mount et al., 2007)] and there is
evidence for phosphorylation of NOS1 (e.g. Zhou and Zhu, 2009)].
Indeed, within the thick ascending limb of the kidney, ET-1 has
been shown to increase NOS3 phosphorylation (Herrera et al., 2009);
however whether this is true for the IMCD remains to be determined.
Protein–protein interactions are also potent stimulators of NOS
activity (e.g. Zhou and Zhu, 2009). We hypothesize that ET-1 acti-
vates a protein–protein interaction to stimulate NOS1 and/or NOS3
activity and an increase in NO production. We recently identiﬁed
that dynamin-2 interacts with NOS1 in the rat and mouse IMCD
(Hyndman et al., 2011). Dynamin-2 interacts with NOS1α as well as
NOS1β leading to a signiﬁcant increase inNOproduction (10). Our future
experiments will be focused on determining whether ET-1 via ETB
receptor increases the interaction between dynamin-2 and NOS1 and
ultimately regulates NO production in IMCD.
Conclusion
The mIMCD-3 in the current study expresses NOS1β, unlike the rat
IMCD, which expresses NOS1α and NOS1β (Hyndman et al., 2011;
Smith et al., 2009), allowing the unique opportunity to study ET-1 regu-
lation ofNOS1β in the collecting duct. ET-1 stimulatesNOproduction, but
it does not regulate NOS1β or NOS3 expression in this system. As well,
ET-1 regulates phosphorylation of ERK1/2, but this signaling cascade is
independent of ET-1 effects on mIMCD-3 NO production. Thus, the sig-
naling cascade involved remains unknown, but likely involves protein–
protein interactions integral in NOS activation and NO production.
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